Alahgholi-Hajibehzad, M. Et Al. 2015. Regulatory function of CD4+CD25++ T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity.. Journal of neuroimmunology , vol.281 , 51-60.

Alahgholi-Hajibehzad, M., Oflazer, P., Aysal, F., Durmus, H., Gulsen-Parman, Y., MARX, A., ... Deymeer, F.(2015). Regulatory function of CD4+CD25++ T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity.. Journal of neuroimmunology , vol.281, 51-60.

Alahgholi-Hajibehzad, Mandi Et Al. "Regulatory function of CD4+CD25++ T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity.," Journal of neuroimmunology , vol.281, 51-60, 2015

Alahgholi-Hajibehzad, Mandi Et Al. "Regulatory function of CD4+CD25++ T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity.." Journal of neuroimmunology , vol.281, pp.51-60, 2015

Alahgholi-Hajibehzad, M. Et Al. (2015) . "Regulatory function of CD4+CD25++ T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity.." Journal of neuroimmunology , vol.281, pp.51-60.

@article{article, author={Mandi Alahgholi-Hajibehzad Et Al. }, title={Regulatory function of CD4+CD25++ T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity.}, journal={Journal of neuroimmunology}, year=2015, pages={51-60} }